panitumumab
takeda,amgen
['paradigm', 'colorectal', 'rectal']
the #oncoalerttoptweet day 3 #asco22 tweet by #paradigm by the ~3 0 month median survival is no longer the overall survival landmark. we see the 3 year mark being crossed for our patients w/metastatic #colorectalcancer best 
?? Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees ?? We are #OncoAlert ??